Fe3 has developed a novel transdermal patch for the treatment of iron-deficiency anemia, one of the world's most prevalent micro-nutrient deficiencies. The Fe3 patch offers an alternative to oral iron for the nearly half of patients who cannot tolerate gastrointestinal side effects of iron pills.
Market
Iron-deficiency anemia treatment
Location
San Antonio,
TX,
USA
Coinvestors
HG Capital, Jianmin Pharmaceuticals, Ping An Ventures